TANG CAPITAL MANAGEMENT LLC Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$815.4B
Holdings
95
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (95 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ANABANAPTYSBIO INC | 2,628,678 | $67.1B | 8.22% | |
| 2 | —BIOHAVEN PHARMACTL HLDG CO L | 280,000 | $42.3B | 5.19% | |
| 3 | —BLUEBIRD BIO INC | 6,335,528 | $40.1B | 4.92% | |
| 4 | TARSTARSUS PHARMACEUTICALS INC | 2,089,856 | $35.8B | 4.39% | |
| 5 | ALTALTIMMUNE INC | 2,600,450 | $33.2B | 4.07% | |
| 6 | ITCIEURINTRA-CELLULAR THERAPIES INC | 640,000 | $29.8B | 3.65% | |
| 7 | HRTXHERON THERAPEUTICS INC | 6,840,000 | $28.9B | 3.54% | |
| 8 | BUWABIO RAD LABS INC | 64,000 | $26.7B | 3.27% | |
| 9 | KALVKALVISTA PHARMACEUTICALS INC | 1,800,000 | $26.1B | 3.20% | |
| 10 | BDQMALBIREO PHARMA INC | 1,099,516 | $21.3B | 2.61% | |
| 11 | RCKTROCKET PHARMACEUTICALS INC | 1,265,900 | $20.2B | 2.48% | |
| 12 | ALNYALNYLAM PHARMACEUTICALS INC | 100,000 | $20.0B | 2.45% | |
| 13 | IMCRIMMUNOCORE HLDGS PLC | 405,600 | $19.0B | 2.33% | |
| 14 | VRDNVIRIDIAN THERAPEUTICS INC | 882,925 | $18.1B | 2.22% | |
| 15 | 5E7ITEOS THERAPEUTICS INC | 937,500 | $17.9B | 2.19% | |
| 16 | BCABBIOATLA INC | 1,967,051 | $15.1B | 1.86% | |
| 17 | BCRXBIOCRYST PHARMACEUTICALS INC | 1,200,000 | $15.1B | 1.85% | |
| 18 | RLMDRELMADA THERAPEUTICS INC | 400,000 | $14.8B | 1.82% | |
| 19 | ONCBEIGENE LTD | 105,000 | $14.2B | 1.74% | |
| 20 | HRMYHARMONY BIOSCIENCES HLDGS IN | 310,000 | $13.7B | 1.68% | |
| 21 | TWTRUSDTWITTER INC | 300,000 | $13.2B | 1.61% | |
| 22 | VERUEURVERU INC | 1,100,000 | $12.7B | 1.55% | |
| 23 | IM8NINSMED INC | 500,000 | $10.8B | 1.32% | |
| 24 | GLPGGALAPAGOS NV | 224,950 | $9.6B | 1.18% | |
| 25 | MIRMMIRUM PHARMACEUTICALS INC | 450,000 | $9.5B | 1.16% | |
| 26 | ISIIONIS PHARMACEUTICALS INC | 200,000 | $8.8B | 1.08% | |
| 27 | NKTXNKARTA INC | 662,872 | $8.7B | 1.07% | |
| 28 | AZNASTRAZENECA PLC | 150,000 | $8.2B | 1.01% | |
| 29 | ALLKGUSDALLAKOS INC | 1,323,393 | $8.1B | 0.99% | |
| 30 | DAWNDAY ONE BIOPHARMACEUTICALS I | 400,000 | $8.0B | 0.98% | |
| 31 | CGEMCULLINAN ONCOLOGY INC | 624,016 | $8.0B | 0.98% | |
| 32 | RVNCEURREVANCE THERAPEUTICS INC | 287,500 | $7.8B | 0.95% | |
| 33 | KNSAKINIKSA PHARMACEUTICALS LTD | 600,000 | $7.7B | 0.94% | |
| 34 | CHRSCOHERUS BIOSCIENCES INC | 750,000 | $7.2B | 0.88% | |
| 35 | IMGNEURIMMUNOGEN INC | 1,500,000 | $7.2B | 0.88% | |
| 36 | ENTAENANTA PHARMACEUTICALS INC | 137,700 | $7.1B | 0.88% | |
| 37 | ASNDASCENDIS PHARMA A/S | 66,090 | $6.8B | 0.84% | |
| 38 | —TCR2 THERAPEUTICS INC | 3,741,606 | $6.7B | 0.83% | |
| 39 | CNCEEURCONCERT PHARMACEUTICALS INC | 1,003,017 | $6.7B | 0.82% | |
| 40 | BBIOBRIDGEBIO PHARMA INC | 585,424 | $5.8B | 0.71% | |
| 41 | RCUSARCUS BIOSCIENCES INC | 200,000 | $5.2B | 0.64% | |
| 42 | CTMXCYTOMX THERAPEUTICS INC | 3,500,000 | $5.1B | 0.62% | |
| 43 | TCE2CELLDEX THERAPEUTICS INC NEW | 160,219 | $4.5B | 0.55% | |
| 44 | GNFTYGENFIT S A | 1,197,522 | $4.4B | 0.54% | |
| 45 | TSVT*2SEVENTY BIO INC | 300,000 | $4.4B | 0.54% | |
| 46 | BNTXBIONTECH SE | 30,000 | $4.0B | 0.50% | |
| 47 | BABAALIBABA GROUP HLDG LTD | 50,000 | $4.0B | 0.49% | |
| 48 | —HEALTH SCIENCES ACQ CORP 2 | 392,500 | $3.9B | 0.48% | |
| 49 | ALDXALDEYRA THERAPEUTICS INC | 700,000 | $3.7B | 0.46% | |
| 50 | —FORTRESS BIOTECH INC | 4,194,483 | $3.6B | 0.44% | |
| 51 | GRPHGRAPHITE BIO INC | 1,100,000 | $3.5B | 0.43% | |
| 52 | SWTXSPRINGWORKS THERAPEUTICS INC | 120,000 | $3.4B | 0.42% | |
| 53 | —ASLAN PHARMACEUTICALS LTD | 5,654,925 | $3.4B | 0.42% | |
| 54 | ESPRESPERION THERAPEUTICS INC NE | 500,000 | $3.4B | 0.41% | |
| 55 | ATYRATYR PHARMA INC | 1,113,453 | $3.3B | 0.41% | |
| 56 | CRSPCRISPR THERAPEUTICS AG | 50,000 | $3.3B | 0.40% | |
| 57 | LEGNLEGEND BIOTECH CORP | 80,000 | $3.3B | 0.40% | |
| 58 | BSFAANI PHARMACEUTICALS INC | 100,000 | $3.2B | 0.39% | |
| 59 | EGRXEAGLE PHARMACEUTICALS INC | 118,857 | $3.1B | 0.39% | |
| 60 | AXSMAXSOME THERAPEUTICS INC | 70,000 | $3.1B | 0.38% | |
| 61 | CLNNEURCLENE INC | 1,100,000 | $3.1B | 0.38% | |
| 62 | GOSSGOSSAMER BIO INC | 250,000 | $3.0B | 0.37% | |
| 63 | PYXSPYXIS ONCOLOGY INC | 1,411,569 | $2.8B | 0.34% | |
| 64 | 2L9BLUEPRINT MEDICINES CORP | 40,000 | $2.6B | 0.32% | |
| 65 | CCXIEURCHEMOCENTRYX INC | 50,000 | $2.6B | 0.32% | |
| 66 | VNDAVANDA PHARMACEUTICALS INC | 256,696 | $2.5B | 0.31% | |
| 67 | ADMAADMA BIOLOGICS INC | 992,840 | $2.4B | 0.30% | |
| 68 | BEAMBEAM THERAPEUTICS INC | 50,000 | $2.4B | 0.29% | |
| 69 | SPRYSILVERBACK THERAPEUTICS INC | 409,463 | $2.2B | 0.27% | |
| 70 | BLUBELLUS HEALTH INC NEW | 200,000 | $2.1B | 0.26% | |
| 71 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 259,054 | $2.0B | 0.25% | |
| 72 | ALGSALIGOS THERAPEUTICS INC | 1,674,166 | $1.8B | 0.23% | |
| 73 | CTIC1USDCTI BIOPHARMA CORP | 300,000 | $1.7B | 0.21% | |
| 74 | TCRXTSCAN THERAPEUTICS INC | 557,915 | $1.7B | 0.21% | |
| 75 | AUPHAURINIA PHARMACEUTICALS INC | 200,000 | $1.5B | 0.18% | |
| 76 | —INSPIRATO INCORPORATED | 612,345 | $1.4B | 0.18% | |
| 77 | —VINCERX PHARMA INC | 1,030,634 | $1.4B | 0.17% | |
| 78 | MRTXEURMIRATI THERAPEUTICS INC | 20,000 | $1.4B | 0.17% | |
| 79 | NKTREURNEKTAR THERAPEUTICS | 430,037 | $1.4B | 0.17% | |
| 80 | EQEQUILLIUM INC | 600,000 | $1.3B | 0.16% | |
| 81 | —TRITIUM DCFC LIMITED | 400,000 | $1.3B | 0.16% | |
| 82 | LPTXEURLEAP THERAPEUTICS INC | 1,250,000 | $1.1B | 0.13% | |
| 83 | DVAXDYNAVAX TECHNOLOGIES CORP | 100,000 | $1.0B | 0.13% | |
| 84 | ORTXUSDORCHARD THERAPEUTICS PLC | 2,000,000 | $1.0B | 0.12% | |
| 85 | ALECALECTOR INC | 100,000 | $946.0M | 0.12% | |
| 86 | —PARDES BIOSCIENCES INC | 500,000 | $925.0M | 0.11% | |
| 87 | ARVNARVINAS INC | 20,000 | $890.0M | 0.11% | |
| 88 | OLMAOLEMA PHARMACEUTICALS INC | 318,926 | $880.0M | 0.11% | |
| 89 | —METACRINE INC | 1,718,220 | $833.0M | 0.10% | |
| 90 | FIXXEURHOMOLOGY MEDICINES INC | 214,898 | $346.0M | 0.04% | |
| 91 | BOLT1EURBOLT BIOTHERAPEUTICS INC | 200,000 | $296.0M | 0.04% | |
| 92 | EOLSEVOLUS INC | 36,514 | $294.0M | 0.04% | |
| 93 | MOLNMOLECULAR PARTNERS AG | 15,681 | $105.0M | 0.01% | |
| 94 | —INSPIRATO INCORPORATED | 365,000 | $88.0M | 0.01% | |
| 95 | —ACELRX PHARMACEUTICALS INC | 388,468 | $81.0M | 0.01% |